DUEY MARC purchased 9.1% of their position (21.46K shares) of APREA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $25.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/11/2025ACC: 0001104659-25-120156
+42.92K
Net shares
Net buyer
$25.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
42.92K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+21.46K
Price / share
$1.17
Trade value
$25K
% of position
9.1%
12/10/2025
234.70K→256.15K
Total
Net shares
+21.46K
Net value
$25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/10/2025 | P · Purchase | +21.46K | $1.17 | $25K | 9.1% | 234.70K | 256.15K |
| Total | +21.46K | $25K | ||||||
Derivative Transactions1
Common Warrant
Direct
Converts to
Common Stock
21.46K shares
Shares
+21.46K
Strike price
1.04
Held after
21.46K
Exercisable
—
12/10/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Warrant Direct | Common Stock21.46K shares | 12/10/2025 | P · Purchase | +21.46K | 1.04 | — | 21.46K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned602.00
Total
602.00 indirect602.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 602.00 | Indirect |
| Total | 602.00 | 602.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported